Verana Health’s exclusive real-world data network and clinically true Qdata™ can help accelerate clinical trials in ophthalmology, urology, and neurology—from study startup through recruitment. From protocol development and clinical trial design to site selection and identifying potential participants*, we help speed patient enrollment to help you meet your recruitment goals. Find out how Verana Health can support your next rare disease, site-based, or multi-disciplinary study.
Clinical Trial Design
Utilize Verana Health’s exclusive Qdata to help refine your protocol design and patient cohort, including both patient and site feasibility analyses. Qdata is derived from exclusive speciality electronic health records (EHRs), so we can help you better understand whether a site will have patients who fit study criteria in near real-time. We can help you refine the inclusion and exclusion criteria to best meet your enrollment and study goals.
Clinical Trial Site Section
Leverage Verana Health’s exclusive Qdata to not just identify, but also engage, clinical trial sites for your upcoming or ongoing study. Qdata contains variables that are key to site selection including: number of providers per practice, counts of complex procedures, generalized, de-identified patient demographics, and previous trial participation history. We can help you optimize for sites with trial experience and high patient volume in your indication of interest.
Utilize Qdata to help locate practices with providers serving patients who fit your protocol inclusion and exclusion criteria. We will create a unique algorithm to apply to Qdata for your specific trial using both structured fields and unstructured physician notes to identify potentially eligible patients. Verana Health will then support site activation for eligible sites and activate Verana Health Trial Connect to identify potentially eligible patients to the providers and research staff treating those patients.
Rare Disease Trials
Verana Health can help practices treating patients with rare conditions match those patients to relevant trials, and if eligible, offer them no-cost genetic testing and counseling.
Verana Health can help practices identify and treat patients who match study inclusion and exclusion criteria, and to refer them to investigators at existing trial sites.
Qdata modules are curated data sets ready for research use to inform real-world evidence (RWE). Qdata is powered by Verana Health’s population health data engine, VeraQ™, which contains rich medical specialty data exclusively found here.
Here is a list of current Qdata modules and those in development, which represent a wide-range of indications across Urology, Ophthalmology, and Neurology.
Qdata for Urology
- Prostate Cancer
- Non-muscle Invasive Bladder Cancer
- Other Early-stage Genitourinary Cancers*
- Overactive Bladder
Qdata for Ophthalmology
- Wet Age-related Macular Degeneration (AMD)
- Dry Age-related Macular Degeneration (AMD)
- Geographic Atrophy
- Diabetic Retinopathy
- Diabetic Macular Edema
- Dry Eye
- Retinal Vein Occlusion
- Retinal Artery Occlusion
- Inherited Retinal Diseases
- Other Ophthalmic Conditions*
Qdata for Neurology
- Spinal Muscular Atrophy (SMA)
- Multiple Sclerosis (MS)
- Neuromyelitis Optica Spectrum Disorder (NMOSD)
- Parkinson's Disease
- Other Neurological Conditions*